Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
10%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
4
31%
Ph not_applicable
6
46%
Ph phase_2
2
15%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
4(33.3%)
N/ANon-phased studies
6(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Terminated(1)
Other(2)

Detailed Status

Completed10
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (16.7%)
Phase 34 (33.3%)
N/A6 (50.0%)

Trials by Status

completed1077%
unknown215%
terminated18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
13